title: A review of calcium supplements and cardiovascular disease risk.
abstract: A group of academic and industry experts in the fields of nutrition, cardiology, epidemiology, food science, bone health, and integrative medicine examined the data on the relationship between calcium supplement use and risk of cardiovascular events, with an emphasis on 4 of the Bradford Hill criteria for causal inference: strength, consistency, dose-response, and biological plausibility. Results from 2 epidemiological studies and a meta-analysis of randomized, controlled clinical trials, including a subgroup analysis from the Women's Health Initiative, have prompted concern about a potential association between calcium supplement use and a small increase in the risk of adverse cardiovascular events. However, a number of issues with the studies, such as inadequate compliance with the intervention, use of nontrial calcium supplements, potential bias in event ascertainment, and lack of information on and adjustment for known cardiovascular risk determinants, suggest that bias and confounding cannot be excluded as explanations for the reported associations. Findings from other cohort studies also suggest no detrimental effect of calcium from diet or supplements, with or without vitamin D, on cardiovascular disease risk. In addition, little evidence exists for plausible biological mechanisms to link calcium supplement use with adverse cardiovascular outcomes. The authors do not believe that the evidence presented to date regarding the hypothesized relationship between calcium supplement use and increased cardiovascular disease risk is sufficient to warrant a change in the Institute of Medicine recommendations, which advocate use of supplements to promote optimal bone health in individuals who do not obtain recommended intakes of calcium through dietary sources.
authors.affiliation: Osteoporosis Research Center, Creighton University Medical Center, Omaha, NE, USA.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Heaney
authors.forename: Stephen
authors.initials: S
authors.lastname: Kopecky
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Maki
authors.forename: John
authors.initials: J
authors.lastname: Hathcock
authors.forename: Douglas
authors.initials: D
authors.lastname: Mackay
authors.forename: Taylor C
authors.initials: TC
authors.lastname: Wallace
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002118:Calcium / Q000009:adverse effects*; D002136:Calcium, Dietary / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control; D019587:Dietary Supplements / Q000009:adverse effects*; D006801:Humans; D012107:Research Design / Q000592:standards; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D002118:Calcium